Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04469790 · ClinicalTrials.gov registry record · NA
Effects of Multi-day Interruptions in Sitting on Type 2 Diabetes-relevant Outcomes in Children
A NA study of Anxiety and Sedentary Behavior, sponsored by University of Southern California.
- Recruiting
- Registry status
- NA
- Development phase
- 188
- Enrollment target
- 1
- Study location
NCT04469790: Recruiting NA study of Anxiety and Sedentary Behavior, sponsored by University of Southern California.
NCT04469790 is a NA study of Anxiety and Sedentary Behavior that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 188 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04469790, a NA study of Anxiety and Sedentary Behavior, is actively recruiting participants, sponsored by University of Southern California.
- RECRUITING
- Registry status
- NA
- Development phase
- 188 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall objective of this in-lab randomized controlled trial is to test the efficacy of multi-day interruptions in sedentary behavior vs. single bouts of sustained exercise on metabolic, cognitive, affective, and cardiac autonomic nervous system responses in children with overweight and obesity who are at risk for type 2 diabetes. The use of continuous glucose monitoring will provide insight into the daily and cumulative metabolic effects of each condition that have thus far not been studied. In-lab studies demonstrating sustained efficacy of this approach in ameliorating negative effects of sedentary behaviors in children are necessary for the optimization of field-based interventions. Given the lack of success of interventions to prevent obesity-related diseases and increasing rates of type 2 diabetes in children and its related healthcare costs, this study addresses a critical public health need by testing of novel intervention strategies to reduce obesity-related diseases in children with overweight and obesity.
Primary Outcome
change in glucose AUC from oral glucose tolerance tests
Conditions Studied
Interventions
- BEHAVIORAL SIT+WALK
- BEHAVIORAL EX
Study Locations (1)
California
- Britni Ryan Belcher, PhD, MPH - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 188 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
What NCT04469790 shows while recruiting
NCT04469790 is an interventional study that assigns participants to a tested intervention. The registered 188 participants enrollment target is mid-sized for trials with a published cap, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (57% lower).
The record links to 5 conditions, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which SIT+WALK is the first listed.
NCT04469790 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04469790 about?
NCT04469790 is a clinical study titled "Effects of Multi-day Interruptions in Sitting on Type 2 Diabetes-relevant Outcomes in Children". The overall objective of this in-lab randomized controlled trial is to test the efficacy of multi-day interruptions in sedentary behavior vs. single bouts of sustained exercise on metabolic, cognitive, affective, and cardiac autonomic nervous system responses in children with overweight and obesity ...
What is the current status of trial NCT04469790?
This trial is currently recruiting. It is a NA study. The enrollment target is 188 participants. The study started on 2022-03-01. Estimated completion is 2026-08-31.
What conditions does trial NCT04469790 study?
This clinical trial studies the following conditions: Anxiety, Sedentary Behavior, Metabolic Disturbance, Affect, Cardiac Autonomic Nervous System Function.
What interventions are being tested in trial NCT04469790?
The interventions under investigation include: SIT+WALK (BEHAVIORAL), EX (BEHAVIORAL).
Who is sponsoring clinical trial NCT04469790?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04469790 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04469790's enrollment target sits among peer trials
188 89th of 364 higher than 275 of 364 other Anxiety trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
-
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
RECRUITING · NA
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422198 · 188 participants · Phase 3
Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer
- NCT04671667 · 188 participants · Phase 2
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
- NCT04853251 · 188 participants · Phase 4
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
- NCT05076110 · 188 participants · Phase 4
Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI